(Q45213094)

10 December 2017

The expression of HMGB1 protein and its receptor RAGE in human malignant tumors (English)

1 reference

10 December 2017

Nora Kostova

1

1 reference

10 December 2017

Stanislava Zlateva

series ordinal

2

1 reference

10 December 2017

Iva Ugrinova

series ordinal

3

1 reference

10 December 2017

Evdokia Pasheva

series ordinal

4

1 reference

10 December 2017

30 October 2009

1 reference

Molecular and Cellular Biochemistry

10 December 2017

1 reference

10 December 2017

337

1 reference

10 December 2017

1-2

1 reference

10 December 2017

251-258

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-009-0305-0

10 December 2017

0 references

cites work

High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11010-009-0305-0

The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11010-009-0305-0

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

21 January 2018

1 reference

12 December 2020

High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes

1 reference

12 December 2020

Specific recognition of cruciform DNA by nuclear protein HMG1.

1 reference

12 December 2020

HMG1 and 2: architectural DNA-binding proteins

1 reference

12 December 2020

High mobility group protein-1 (HMG-1) is a unique activator of p53

1 reference

12 December 2020

Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer

1 reference

12 December 2020

Secretion and binding of HMG1 protein to the external surface of the membrane are required for murine erythroleukemia cell differentiation.

1 reference

12 December 2020

Differential expression of nuclear HMG1, HMG2 proteins and H1(zero) histone in various blood cells

1 reference

12 December 2020

Expression of high-mobility group-1 mRNA in human gastrointestinal adenocarcinoma and corresponding non-cancerous mucosa

1 reference

12 December 2020

HMGB proteins and gene expression

1 reference

12 December 2020

Revised nomenclature for high mobility group (HMG) chromosomal proteins

1 reference

12 December 2020

Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin

1 reference

12 December 2020

Masquerader: high mobility group box-1 and cancer

1 reference

12 December 2020

Regulation of cell migration by amphoterin.

1 reference

12 December 2020

Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs

1 reference

12 December 2020

Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells

1 reference

12 December 2020

Variation of HMGB1 expression in breast cancer

1 reference

12 December 2020

The nuclear protein HMGB1, a new kind of chemokine?

1 reference

12 December 2020

RAGE expression in rhabdomyosarcoma cells results in myogenic differentiation and reduced proliferation, migration, invasiveness, and tumor growth.

1 reference

12 December 2020

HMG1 interacts with HOX proteins and enhances their DNA binding and transcriptional activation

1 reference

12 December 2020

The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells

1 reference

12 December 2020

Preferential binding of high mobility group 1 protein to UV-damaged DNA. Role of the COOH-terminal domain

1 reference

12 December 2020

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

1 reference

12 December 2020

Upwardly mobile proteins. Workshop: the role of HMG proteins in chromatin structure, gene expression and neoplasia

1 reference

12 December 2020

Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways

1 reference

12 December 2020

Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma

1 reference

12 December 2020

Altered expression and localization of creatine kinase B, heterogeneous nuclear ribonucleoprotein F, and high mobility group box 1 protein in the nuclear matrix associated with colon cancer

1 reference

12 December 2020

Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer.

1 reference

12 December 2020

Differential effects between amphoterin and advanced glycation end products on colon cancer cells

1 reference

12 December 2020

Amphoterin induction in prostatic stromal cells by androgen deprivation is associated with metastatic prostate cancer

1 reference

12 December 2020

HMG-1 as a late mediator of endotoxin lethality in mice

1 reference

12 December 2020

Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.

1 reference

12 December 2020

Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype

1 reference

12 December 2020

Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas

1 reference

12 December 2020

Expression of receptor for advanced glycation end products and HMGB1/amphoterin in colorectal adenomas

1 reference

12 December 2020

Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function

1 reference

12 December 2020

Amphoterin as an extracellular regulator of cell motility: from discovery to disease.

1 reference

12 December 2020

10.1007/S11010-009-0305-0

Identifiers

DOI

1 reference

Dimensions Publication ID

10 December 2017

0 references

1 reference